[1] HUNDAHL SA, CADY B, CUNNINGHAM MP, et al. Initial results from a prospective cohort study of 5583 cases of thyroid carcinoma treated in the united states during 1996. U.S. and German Thyroid Cancer Study Group. An American college of surgeons commission on cancer patient care evaluation study[J]. Cancer, 2000, 89(1): 202. doi: 10.1002/1097-0142(20000701)89:1<202::AID-CNCR27>3.0.CO;2-A
[2] SCIUTO R, ROMANO L, REA S, et al. Natural history and clinical outcome of differentiated thyroid carcinoma: a retrospective analysis of 1503 patients treated at a single institution[J]. Ann Oncol, 2009, 20(10): 1728. doi: 10.1093/annonc/mdp050
[3] HAUGEN BR. 2015 American thyroid association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: What is new and what has changed?[J]. Cancer, 2017, 123(3): 372. doi: 10.1002/cncr.30360
[4] HAUGEN BR, ALEXANDDER EK, BIBLE KC, et al. 2015 American thyroid association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American thyroid association guidelines task force on thyroid nodules and differentiated thyroid cance[J]. Thyroid, 2016, 26(1): 1. doi: 10.1089/thy.2015.0020
[5] 中华人民共和国国家卫生健康委员会. 甲状腺癌诊疗规范(2018年版)[J/CD]. 中华普通外科学文献(电子版), 2019, 13(1): 1.
[6] KLAIN M, PACE L, ZAMPELLA E, et al. Outcome of patients with differentiated thyroid cancer treated With 131-Iodine on the basis of a detectable serum thyroglobulin level after initial treatment[J]. Front Endocrinol(Lausanne), 2019, 10: 146. doi: 10.3389/fendo.2019.00146
[7] SLOOK O, LEVY S, SLUTZKY-SHRAGA I, et al. Long-term outcomes and prognostic factors in patients with differentiated thyroid carcinoma and bone metastases[J]. Endocr Pract, 2019, 25(5): 427. doi: 10.4158/EP-2018-0465
[8] 中华医学会内分泌学分会, 中华医学会外科学分会内分泌学组, 中国抗癌协会头颈肿瘤专业委员会, 等. 甲状腺结节和分化型甲状腺癌诊治指南[J]. 中华核医学与分子影像杂志, 2013, 32(2): 96. doi: 10.3760/cma.j.issn.2095-2848.2013.02.003
[9] REN L, ZHANG C, SHEN Y, et al. The value of stimulated thyroglobulin before the first radioactive iodine treatment in metastasis for differentiated thyroid carcinoma(DTC)[J]. Clin Lab, 2021, 67(6).
[10] 胡永全, 申勇, 袁超, 等. 131I治疗分化型甲状腺癌肺转移的疗效及影响因素分析[J]. 蚌埠医学院学报, 2019, 44(1): 34.
[11] 林岩松. 有关分化型甲状腺癌核医学相关诊治的指南更新[J]. 中华核医学与分子影像杂志, 2018, 38(3): 172. doi: 10.3760/cma.j.issn.2095-2848.2018.03.006
[12] YANG X, LIANG J, LI T, et al. Preablative stimulated thyroglobulin correlates to new therapy response system in differentiated thyroid cancer[J]. J Clin Endocrinol Metab, 2016, 101(3): 1307. doi: 10.1210/jc.2015-4016
[13] ZHANG L, ZOU G. Role of thyroid ultrasound combined with thyroglobulin in the diagnosis of postoperative recurrence of thyroid cancer[J]. Minerva Endocrinol, 2019, 44(2): 192.
[14] VERBURG FA, MADER U, GIOVANELLA L, et al. Low or undetectable basal thyroglobulin levels obviate the need for neck ultrasound in differentiated thyroid cancer patients after total thyroidectomy and(131)I ablation[J]. Thyroid, 2018, 28(6): 722. doi: 10.1089/thy.2017.0352
[15] 杨晓惠. 基于TI-RADS的超声细化计分法和血清TSH值联合鉴别甲状腺结节良恶性[J]. 蚌埠医学院学报, 2019, 44(6): 771.